Faculty Profiles - HOTTA Katsuyuki

Papers - HOTTA Katsuyuki

Division display 181 - 192 of about 192 ／ All the affair displays >>

堀田勝幸, 上岡博, 木浦勝行, 田端雅弘, 藤原慶一, 久本晃子, 岡田俊明, 上月稔幸, 谷本光音

肺癌 43 ( 5 ) 586 - 586 2003.10

非小細胞肺癌(NSCLC)株を用いた新規分子標的治療薬Gefitinibによるsenescence誘導に関する検討(EVIDENCE OF GEFITINIB ("IRESSA", ZD1839)-INDUCED SENESCENT-LIKE GROWTH ARREST IN NON-SMALL-CELL LUNG CANCER (NSCLC) CELLS)

堀田勝幸, 田端雅弘, 木浦勝行, 片山英樹, 上岡博, 谷本光音

日本癌学会総会記事 62回 359 - 359 2003.8

化学療法前後に樹立された非小細胞肺癌株EBC-2とEBC-2/RにおけるZD1839の感受性の差異の検討(Effect of the EGFR tyrosine kinase inhibitor ZD1839 in a ZD1839 sensitive non-small cell lung cancer cell line)

片山英樹, 田端雅弘, 木浦勝行, 堀田勝幸, 上岡博, 谷本光音

日本癌学会総会記事 62回 358 - 358 2003.8

【肺癌治療の個別化】肺癌の病期と治療

木浦勝行, 堀田勝幸, 田端雅弘, 上岡博, 西井研治

肺癌の臨床 5 ( 3 ) 247 - 253 2003.5

進行非小細胞肺癌(NSCLC)患者におけるイリノテカン(I)とパクリタキセル(P)の分割投与法(I/P)の第I相試験

堀田勝幸, 上岡博, 田端雅弘, 木浦勝行, 久山彰一, 谷本光音

日本呼吸器学会雑誌 41 ( 増刊 ) 210 - 210 2003.3

【肺がんの分子生物学・バイオセラピーの現状と将来】肺がんにおけるHER2/neuの意義

久山彰一, 堀田勝幸, 田端雅弘, 木浦勝行, 上岡博

肺癌の臨床 5 ( 2 ) 175 - 180 2003.1

Successful treatment of limited disease-small cell lung cancer with multimodality treatment consisting of concurrent chemoradiotherapy, high-dose chemotherapy with autologous peripheral blood stem cell transplantation and surgical resection Reviewed

Katsuyuki Hotta, Hiroshi Ueoka, Katsuyuki Kiura, Masahiro Tabata, Eisei Kondoh, Yoshihiko Segawa, Hiroshi Date, Nobuyoshi Shimizu, Tadashi Yoshino, Mine Harada, Mitsune Tanimoto

Internal Medicine 42 ( 12 ) 1223 - 1227 2003

Language：English Publishing type：Research paper (scientific journal) Publisher：Japanese Society of Internal Medicine

A 65-year-old man with limited disease-small cell lung cancer was treated with concurrent chemoradiotherapy which resulted in a partial response. He further received high-dose chemotherapy with autologous peripheral blood stem cell transplantation. Development of non-small cell carcinoma was, however, suspected at a site of the residual nodule in cytological examination using bronchoscopy. He then underwent lobectomy, which revealed that the nodule was composed of necrotic tissue. He has been alive without recurrence for seven years. This multimodality treatment appeared to be effective for this patient. However, further investigation is necessary to clarify the role of multimodality treatment.

DOI： 10.2169/internalmedicine.42.1223

Scopus

PubMed

researchmap

進行非小細胞肺癌(NSCLC)に対するパクリタキセル(P)+イリノテカン(C)併用療法の臨床第I相試験

市川裕久, 堀田勝幸, 久山彰一, 岸野大蔵, 藤本伸一, 見元淳子, 田端雅弘, 木浦勝行, 上岡博, 谷本光音

肺癌 42 ( 6 ) 651 - 651 2002.10